Rebecca E McIntyre

Principal Staff Scientist

Wellcome Sanger Institute
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Most genetic variants associated with complex diseases lie in non-coding regions, complicating efforts to identify effector genes and relevant cell types. Here, we map cis-eQTLs across 2.2 million single cells from blood and intestinal biopsies of 421 individuals, including 125 with inflammatory bowel disease (IBD). Cell-type-level eQTLs were more distal to transcription start sites, enriched in enhancers, less likely to regulate the nearest gene, and over two-fold more likely to colocalise with IBD GWAS loci than eQTLs detected at tissue-level resolution. We nominate effector genes at over half of known IBD loci, including MAML2 , PSEN2, and ZMIZ1 in myeloid cells, implicating reduced Notch signalling in intestinal immune dysfunction. We also identify Wnt regulated genes, including MYC , in epithelial stem and progenitor cells, suggesting that impaired renewal contributes to barrier breakdown. Our results provide a mechanistic map linking genetic risk to specific genes and cell types in IBD, and a framework for effector gene discovery in complex disease.

Year:

2025

Genomic instability arising from defective responses to DNA damage 1 or mitotic chromosomal imbalances 2 can lead to the sequestration of DNA in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark of ageing and diseases associated with genomic instability, the catalogue of genetic players that regulate the generation of MN remains to be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases ( n = 71) or decreases ( n = 74) MN formation, including many genes whose orthologues are linked to human disease. We found that mice null for Dscc1 , which showed the most significant increase in MN, also displayed a range of phenotypes characteristic of patients with cohesinopathy disorders. After validating the DSCC1 -associated MN instability phenotype in human cells, we used genome-wide CRISPR–Cas9 screening to define synthetic lethal and synthetic rescue interactors. We found that the loss of SIRT1 can rescue phenotypes associated with DSCC1 loss in a manner paralleling restoration of protein acetylation of SMC3. Our study reveals factors involved in maintaining genomic stability and shows how this information can be used to identify mechanisms that are relevant to human disease biology 1 .

Year:

2024

Year:

2023

Collaborators (17)

Natalie Prescott

King’s College London

UNITED KINGDOM
View details

Carl Anderson

Head of Human Genetics

Wellcome Sanger Institute

UNITED KINGDOM
View details

Tim Raine

Cambridge University Hospitals NHS Foundation Trust

UNITED KINGDOM
View details

Gareth-Rhys Jones

Clinical Lecturer

-

UNITED KINGDOM
View details

Miles Parkes

Professor

Cambridge University Hospitals

UNITED KINGDOM
View details

Cristina Cotobal

Senior Staff Scientist

Wellcome Sanger Institute

UNITED KINGDOM
View details

Tobi Alegbe

Single-cell data scientist

European Bioinformatics Institute

UNITED KINGDOM
View details

Gabriel Balmus

Principal Investigator

University of Cambridge

UNITED KINGDOM
View details

James L Alexander

Academic Clinical Lecturer

Imperial College Healthcare NHS Trust

UNITED KINGDOM
View details

Panteleimon Takis

Assistant Professor

University of Ioannina

GREECE
View details

Elena Chekmeneva

Research Associate Structure Elucidation

Imperial College London

UNITED KINGDOM
View details

Chris Wallace

Director of Research

University of Cambridge

UNITED KINGDOM
View details

David Adams

Senior Group Leader (and Interim Programme Head)

Wellcome Sanger Institute

UNITED KINGDOM
View details

Peter Irving

King’s College London

UNITED KINGDOM
View details

Stefan Geyer

Associate Professor

Medical University of Vienna

AUSTRIA
View details

Ruth Verstraten

Wellcome Sanger Institute

UNITED KINGDOM
View details

Christopher A. Lamb

Professor of Gastroenterology

Newcastle University

UNITED KINGDOM
View details